vs
Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and HARROW, INC. (HROW). Click either name above to swap in a different company.
HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $58.8M, roughly 1.5× CBAK Energy Technology, Inc.). HARROW, INC. runs the higher net margin — 7.4% vs -12.5%, a 20.0% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs 33.3%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $8.1M). Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs -0.0%).
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
CBAT vs HROW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.8M | $89.1M |
| Net Profit | $-7.4M | $6.6M |
| Gross Margin | 7.3% | 79.3% |
| Operating Margin | -13.6% | 17.5% |
| Net Margin | -12.5% | 7.4% |
| Revenue YoY | 131.8% | 33.3% |
| Net Profit YoY | -63.6% | -2.2% |
| EPS (diluted) | $-0.08 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.8M | $89.1M | ||
| Q3 25 | $60.9M | $71.6M | ||
| Q2 25 | $40.5M | $63.7M | ||
| Q1 25 | $34.9M | $47.8M | ||
| Q4 24 | $25.4M | $66.8M | ||
| Q3 24 | $44.6M | $49.3M | ||
| Q2 24 | $47.8M | $48.9M | ||
| Q1 24 | $58.8M | $34.6M |
| Q4 25 | $-7.4M | $6.6M | ||
| Q3 25 | $2.7M | $1.0M | ||
| Q2 25 | $-3.1M | $5.0M | ||
| Q1 25 | $-1.6M | $-17.8M | ||
| Q4 24 | $-4.5M | $6.8M | ||
| Q3 24 | $17.6K | $-4.2M | ||
| Q2 24 | $6.4M | $-6.5M | ||
| Q1 24 | $9.8M | $-13.6M |
| Q4 25 | 7.3% | 79.3% | ||
| Q3 25 | 8.0% | 75.3% | ||
| Q2 25 | 11.0% | 74.5% | ||
| Q1 25 | 13.7% | 67.5% | ||
| Q4 24 | 13.1% | 78.8% | ||
| Q3 24 | 15.6% | 75.6% | ||
| Q2 24 | 26.6% | 74.4% | ||
| Q1 24 | 31.9% | 69.5% |
| Q4 25 | -13.6% | 17.5% | ||
| Q3 25 | -6.6% | 20.6% | ||
| Q2 25 | -8.7% | 17.9% | ||
| Q1 25 | -8.2% | -23.5% | ||
| Q4 24 | -26.0% | 19.3% | ||
| Q3 24 | -1.9% | 2.7% | ||
| Q2 24 | 12.4% | 3.1% | ||
| Q1 24 | 17.4% | -20.0% |
| Q4 25 | -12.5% | 7.4% | ||
| Q3 25 | 4.4% | 1.4% | ||
| Q2 25 | -7.6% | 7.8% | ||
| Q1 25 | -4.5% | -37.2% | ||
| Q4 24 | -17.8% | 10.1% | ||
| Q3 24 | 0.0% | -8.6% | ||
| Q2 24 | 13.5% | -13.2% | ||
| Q1 24 | 16.7% | -39.2% |
| Q4 25 | $-0.08 | $0.20 | ||
| Q3 25 | $0.03 | $0.03 | ||
| Q2 25 | $-0.03 | $0.13 | ||
| Q1 25 | $-0.02 | $-0.50 | ||
| Q4 24 | $-0.05 | $0.19 | ||
| Q3 24 | $0.00 | $-0.12 | ||
| Q2 24 | $0.07 | $-0.18 | ||
| Q1 24 | $0.11 | $-0.38 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $72.9M |
| Total DebtLower is stronger | $4.1M | $250.0M |
| Stockholders' EquityBook value | $112.7M | $52.4M |
| Total Assets | $426.2M | $399.5M |
| Debt / EquityLower = less leverage | 0.04× | 4.77× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | $72.9M | ||
| Q3 25 | $10.5M | $74.3M | ||
| Q2 25 | $45.7M | $53.0M | ||
| Q1 25 | $9.6M | $66.7M | ||
| Q4 24 | $11.0M | $47.2M | ||
| Q3 24 | $24.2M | $72.6M | ||
| Q2 24 | $44.1M | $71.0M | ||
| Q1 24 | $23.8M | $76.0M |
| Q4 25 | $4.1M | $250.0M | ||
| Q3 25 | $4.8M | $347.2M | ||
| Q2 25 | $4.9M | $250.6M | ||
| Q1 25 | $4.1M | $256.9M | ||
| Q4 24 | — | $262.7M | ||
| Q3 24 | — | $230.7M | ||
| Q2 24 | — | $236.3M | ||
| Q1 24 | — | $243.4M |
| Q4 25 | $112.7M | $52.4M | ||
| Q3 25 | $121.4M | $47.0M | ||
| Q2 25 | $118.2M | $49.7M | ||
| Q1 25 | $120.8M | $56.5M | ||
| Q4 24 | $121.7M | $69.7M | ||
| Q3 24 | $131.2M | $58.0M | ||
| Q2 24 | $126.6M | $58.5M | ||
| Q1 24 | $120.9M | $60.6M |
| Q4 25 | $426.2M | $399.5M | ||
| Q3 25 | $363.9M | $363.1M | ||
| Q2 25 | $333.1M | $345.0M | ||
| Q1 25 | $311.5M | $364.2M | ||
| Q4 24 | $302.2M | $389.0M | ||
| Q3 24 | $293.5M | $351.5M | ||
| Q2 24 | $279.6M | $306.6M | ||
| Q1 24 | $286.5M | $295.5M |
| Q4 25 | 0.04× | 4.77× | ||
| Q3 25 | 0.04× | 7.39× | ||
| Q2 25 | 0.04× | 5.05× | ||
| Q1 25 | 0.03× | 4.55× | ||
| Q4 24 | — | 3.77× | ||
| Q3 24 | — | 3.98× | ||
| Q2 24 | — | 4.04× | ||
| Q1 24 | — | 4.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.8M | $8.4M |
| Free Cash FlowOCF − Capex | $16.1M | $8.1M |
| FCF MarginFCF / Revenue | 27.3% | 9.1% |
| Capex IntensityCapex / Revenue | 23.4% | 0.4% |
| Cash ConversionOCF / Net Profit | — | 1.27× |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | $43.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.8M | $8.4M | ||
| Q3 25 | $14.6M | $16.6M | ||
| Q2 25 | $13.8M | $-803.0K | ||
| Q1 25 | $-9.6M | $19.7M | ||
| Q4 24 | $9.6M | $-17.8M | ||
| Q3 24 | $19.7M | $3.0M | ||
| Q2 24 | $2.9M | $-2.7M | ||
| Q1 24 | $7.4M | $-4.6M |
| Q4 25 | $16.1M | $8.1M | ||
| Q3 25 | $6.0M | $16.4M | ||
| Q2 25 | $4.1M | $-969.0K | ||
| Q1 25 | $-22.3M | $19.5M | ||
| Q4 24 | $3.9M | $-18.3M | ||
| Q3 24 | $16.5M | $2.3M | ||
| Q2 24 | $2.5M | $-3.1M | ||
| Q1 24 | $-454.0K | $-4.7M |
| Q4 25 | 27.3% | 9.1% | ||
| Q3 25 | 9.9% | 22.9% | ||
| Q2 25 | 10.2% | -1.5% | ||
| Q1 25 | -63.9% | 40.8% | ||
| Q4 24 | 15.5% | -27.4% | ||
| Q3 24 | 37.1% | 4.8% | ||
| Q2 24 | 5.2% | -6.3% | ||
| Q1 24 | -0.8% | -13.6% |
| Q4 25 | 23.4% | 0.4% | ||
| Q3 25 | 14.1% | 0.3% | ||
| Q2 25 | 23.8% | 0.3% | ||
| Q1 25 | 36.3% | 0.4% | ||
| Q4 24 | 22.5% | 0.8% | ||
| Q3 24 | 7.0% | 1.2% | ||
| Q2 24 | 0.9% | 0.7% | ||
| Q1 24 | 13.4% | 0.3% |
| Q4 25 | — | 1.27× | ||
| Q3 25 | 5.51× | 16.26× | ||
| Q2 25 | — | -0.16× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -2.62× | ||
| Q3 24 | 1115.72× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
HROW
Segment breakdown not available.
